SCHEMBL8182708

SCHEMBL8182708

O=C1NC(=O)/C(=C\C=C\C=C\c2cc3ccccc3s2)S1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 4/20 0.68
▸ CYP2A6 P11509 1/20 0.43
▸ PIM1 P11309 2/20 0.41
▸ PIM2 Q9P1W9 2/20 0.41
▸ PIM3 Q86V86 1/20 0.41
▸ AKR1B1 P15121 4/20 0.41
▸ TTR P02766 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ MGAM O43451 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ SI P14410 1/20 0.38
▸ MGAM2 Q2M2H8 1/20 0.38
▸ NR1H4 Q96RI1 1/20 0.38
▸ NAT1 P18440 1/20 0.37
▸ IGF1R P08069 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ TUBB4A P04350 2/20 0.36
▸ TUBB P07437 2/20 0.36
▸ TUBA3C P0DPH7 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8182711 1.00 GSK3B (0.68) GSK3BCYP2A6PIM1PIM2PIM3
SCHEMBL8180533 0.95 GSK3B (0.71) GSK3BCYP2A6PIM1PIM2PIM3
SCHEMBL8167446 0.82 GSK3B (0.54) GSK3BCYP2A6PIM1MEN1KMT2A
SCHEMBL8182589 0.75 GSK3B (0.43) GSK3BCYP2A6TUBB4ATUBBTUBA3C
SCHEMBL8181630 0.72 PIM1 (0.54) GSK3BPIM1PIM2PIM3AKR1B1
SCHEMBL8187128 0.72 PIM1 (0.53) GSK3BPIM1PIM2PIM3AKR1B1
SCHEMBL8181632 0.72 PIM1 (0.54) GSK3BPIM1PIM2PIM3AKR1B1
SCHEMBL22409598 0.71 AKR1B1 (0.51) GSK3BPIM1PIM2PIM3AKR1B1
SCHEMBL22423776 0.71 AKR1B1 (0.51) GSK3BPIM1PIM2PIM3AKR1B1
SCHEMBL6002690 0.70 CYP2A6 (0.53) GSK3BCYP2A6MEN1KMT2ATUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018746-A1 THIAZOLIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 — — WO disclosed
Send feedback